Shark cartilage extract produces no anti-cancer effects in latest study


Results of a new study led by Charles Lu of the University of Texas MD Anderson Cancer Center in Houston defies the alternative hypothesis that shark cartilage extract has anti-cancer effects in lung cancer patients.


This study involved 397 participants with non–small cell lung cancer.

- Half received AE-941 (Neovastat, shark cartilage extract)
- Half received a placebo
- All 397 patients also received radiation and chemotherapy.


The AE-941 shark cartilage extract exhibited no effect on:

- progression of cancer
- tumor response
- length of survival


This study, carried out by a highly reputable cancer center and published in a peer-reviewed journal, should give oncologists research on shark cartilage extract to point out to their patients seeking answers about whether or not shark cartilage extract contains any anti-cancer effects.


This study appears in the June 16 issue of the Journal of the National Cancer Institute.

By Ross Bonander


LymphomaInfo Social